MIRA advances Ketamir-2 in the clinic for neuropathic pain while broadening development into neuropsychiatric disorders such ...
Pilot study met key 3-month efficacy endpoint with strong statistical significance (p=0.014); Revita-treated patients lost an ...
“BullFrog AI is committed to advancing data integrity and reliability in the drug development process,” said Vin Singh, Founder and CEO of BullFrog AI. “This webinar demonstrates how our technologies ...
Bankruptcy prediction has traditionally relied on statistical approaches such as Altman’s Z-score, which use financial ratios ...
Good morning, ladies and gentlemen, and welcome to aTyr Pharma conference call to review the top line results for the Phase III EFZO-FIT study of efzofitimod in pulmonary sarcoidosis. [Operator ...
Across the world, marriages are being destroyed as spouses use AI like OpenAI's ChatGPT to attack their partners.
Longevity doctors warn GLP-1 drugs may cost patients muscle, not just fat. ShapeScale’s 3D scans reveal the loss—and help ...
The integration of artificial intelligence in financial systems has become a defining trend of 2025, and Trixford Fund ...
Detailed price information for Acadia Pharmaceutica (ACAD-Q) from The Globe and Mail including charting and trades.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback